169 related articles for article (PubMed ID: 10445371)
1. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential.
Rush CR; Frey JM; Griffiths RR
Psychopharmacology (Berl); 1999 Jul; 145(1):39-51. PubMed ID: 10445371
[TBL] [Abstract][Full Text] [Related]
2. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
[TBL] [Abstract][Full Text] [Related]
3. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
[TBL] [Abstract][Full Text] [Related]
4. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
Evans SM; Funderburk FR; Griffiths RR
J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
[TBL] [Abstract][Full Text] [Related]
5. Electroencephalographic properties of zaleplon, a non-benzodiazepine sedative/hypnotic, in rats.
Noguchi H; Kitazumi K; Mori M; Shiba T
J Pharmacol Sci; 2004 Mar; 94(3):246-51. PubMed ID: 15037809
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
7. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
Rush CR; Baker RW; Wright K
Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
[TBL] [Abstract][Full Text] [Related]
8. Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents.
Griebel G; Perrault G; Sanger DJ
J Psychopharmacol; 1998; 12(4):356-65. PubMed ID: 10065909
[TBL] [Abstract][Full Text] [Related]
9. Zaleplon - a review of a novel sedative hypnotic used in the treatment of insomnia.
Heydorn WE
Expert Opin Investig Drugs; 2000 Apr; 9(4):841-58. PubMed ID: 11060714
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of zaleplon, zolpidem, and triazolam at various GABA(A) receptor subtypes.
Sanna E; Busonero F; Talani G; Carta M; Massa F; Peis M; Maciocco E; Biggio G
Eur J Pharmacol; 2002 Sep; 451(2):103-10. PubMed ID: 12231378
[TBL] [Abstract][Full Text] [Related]
11. Zolpidem and triazolam interact differentially with a delay interval on a digit-enter-and-recall task.
Rush CR; Baker RW
Hum Psychopharmacol; 2001 Mar; 16(2):147-157. PubMed ID: 12404585
[TBL] [Abstract][Full Text] [Related]
12. Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers.
Rush CR; Griffiths RR
J Clin Psychopharmacol; 1996 Apr; 16(2):146-57. PubMed ID: 8690830
[TBL] [Abstract][Full Text] [Related]
13. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons.
Ator NA
Drug Alcohol Depend; 2000 Dec; 61(1):55-68. PubMed ID: 11064184
[TBL] [Abstract][Full Text] [Related]
14. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
Johnson MW; Suess PE; Griffiths RR
Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
[TBL] [Abstract][Full Text] [Related]
16. Zaleplon and triazolam physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
Ator NA; Weerts EM; Kaminski BJ; Kautz MA; Griffiths RR
Drug Alcohol Depend; 2000 Dec; 61(1):69-84. PubMed ID: 11064185
[TBL] [Abstract][Full Text] [Related]
17. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
18. Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects.
Carter LP; Griffiths RR; Suess PE; Casada JH; Wallace CL; Roache JD
J Pharmacol Exp Ther; 2007 Aug; 322(2):749-59. PubMed ID: 17502431
[TBL] [Abstract][Full Text] [Related]
19. A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
Rush CR; Ali JA
Exp Clin Psychopharmacol; 1999 Aug; 7(3):257-65. PubMed ID: 10472514
[TBL] [Abstract][Full Text] [Related]
20. Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.
Mintzer MZ; Griffiths RR
Drug Alcohol Depend; 1998 Dec; 53(1):49-66. PubMed ID: 10933340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
